Taken together, these findings along with clinical evidence of TGFβ receptor silencing suggests that reconstitution of TGFβ receptor expression could lead to inhibition of growth and/or induce apoptosis in highly progressed metastatic colon cancer cells by the TGFβ/PKA signaling pathway. This evidence concerns the gene TGFB1 and malignant colon neoplasm.